Community Funding Opportunities

Health Services Research on Minority Health & Health Disparities (R21)

Due Date: 01-09-2017
The purpose of this FOA is to encourage innovative exploratory and developmental health services research to improve minority health and/or reduce health disparities at the health care system-level as well as within clinical settings. R01 also available

Southeast Rural Community Assistance Project Loan Fund

Due Date: 11-16-2017
The fund provides low-interest loans to low-income rural communities for predevelopment costs, system upgrades, and new construction of water and wastewater services and facilities. Loans are also available for housing and community development.

Walmart Community Grant Program 2017

Due Date: 12-31-2017
Walmart and the Walmart Foundation believes in operating globally and giving back locally. Through the program, their associates are proud to support the needs of their communities by providing grants to local organizations.

Title X Family Planning Grants

Due Date: 01-03-2018
The U.S. Department of Health and Human Services, Office of the Assistant Secretary for Health seeks applications from public and private nonprofit entities to establish and operate voluntary family planning services projects, which shall provide family planning services to all persons desiring such services, with priority for services to persons from low-income families.

Columbia Medical Center Invites Applications for Summer Program for Underrepresented Students

Due Date: 02-02-2018
This biomedical research program at Columbia University Medical Center, is accepting applications for the 2018 summer session. The internship program is designed to expand the pool of medical and biomedical research applicants from diverse and economically disadvantaged groups whose members have been underrepresented in medicine and biomedical research, including African Americans, Hispanic Americans, Native Americans, and Pacific Islanders.

President's Council on Fitness, Sports, & Nutrition (PCFSN) Community Leadership Award

Due Date: 03-01-2018
The award is given annually to no more than 50 individuals or organizations that provide or enhance opportunities to engage in sports, physical activity, fitness, or nutrition-related programs within a community.

Buffett Family Foundation Pledged $90 Million to Aid Young Women of Color

The money will be deployed by the NoVo Foundation via three streams to fund: 1) community-based organizations¿ budget line items on continuing operations; 2) organizations and efforts in the southeastern U.S. in concert with a yet-undetermined regional partner. This money will also be used to form new organizations necessary to affect change and to fund individual efforts that may exist outside of established organizations; 3) broader concerns on a national level, including research organizations and policy change measures.

Breast Health Outreach Grants

The Avon Breast Health Outreach Program (BHOP) provides grants to nonprofit organizations to conduct outreach, provide education on breast health and breast cancer screening, link medically underserved women to care providers and clinical screening services, and help navigate patients through any necessary follow-up care.

Discovery Funding Opportunities

BRAIN Initiative: Proof of Concept Development of Early Stage Next Generation Human Brain Imaging (R01)

Due Date: 12-20-2017
This FOA aims to support full development of entirely new or next generation noninvasive human brain imaging tools and methods that will lead to transformative advances in our understanding of the human brain. The FOA seeks innovative applications that are ready for full-scale development of breakthrough technologies with the intention of delivering working tools within the timeframe of the BRAIN Initiative.

BRAIN Initiative: Development of Next Generation Human Brain Imaging Tools & Technologies (U01)

Due Date: 12-20-2017
This FOA aims to support full development of entirely new or next generation noninvasive human brain imaging tools and methods that will lead to transformative advances in our understanding of the human brain. The FOA seeks innovative applications that are ready for full-scale development of breakthrough technologies with the intention of delivering working tools within the timeframe of the BRAIN Initiative.

American Lung Association/AAAAO Allergic Respiratory Diseases Award

Due Date: 12-21-2017
The goals of this program are to foster laboratory, patient-centered and social-behavioral research designed to prevent and relieve the suffering associated with all lung diseases and corresponding risk factors and to fund researchers at important crossroads of their careers to gain long-term commitment to lung disease research.

Collaborative Program Grant for Multidisciplinary Teams (RM1)

Due Date: 12-25-2017
This FOA is designed to support highly integrated research teams of three to six PD/PIs to address ambitious and challenging research questions that are important for the mission of NIGMS and are beyond the scope of an individual or a few investigators.

Innovation award for mechanistic studies to optimize mind & body interventions in NCCIH high priority research topics (R33 clinical trial required)

Due Date: 01-02-2018
Building on prior mechanistic research, the purpose of this FOA is to encourage additional research to optimize the biological, neurological, physiological mechanisms or behavioral processes underlying Mind and Body Interventions.

Testing interventions for health-enhancing physical activity (R01-clinical trial optional)

Due Date: 01-05-2018
The purpose of this FOA is to fund highly innovative and promising research that tests multi-level physical activity intervention programs acting on at least two levels of the socio-ecological model and designed to increase health-enhancing physical activity: 1) in persons or groups that can benefit from such activity; and 2) that could be made scalable and sustainable for broad use across the nation.

Clinic Testing Therapeutic/Indication Pairing Strategies

Due Date: 01-05-2018
This FOA invites applications for support of clinical studies to repurpose existing drugs or biologics (therapeutics) that have already completed at least a Phase l trial for a different indication by the time an award is made.

2018-2019 Emory University Research Committee (URC) Call for Proposals

Due Date: 01-08-2018
Emory¿s University Research Committee announces the annual Call for Proposals for the 2018-2019 funding cycle in the following categories: Regular URC, URC-Georgia CTSA (Georgia Clinical & Translational Science Alliance), and URC-Halle Institute for Global Research and Learning International Research Awards. Applications are welcome from all regular, full-time Emory faculty members, regardless of rank.

Mobile & Connected Health Interventions to Improve Care Continuum & Health Outcomes among Youth with HIV (R34 & R01)

Due Date: 01-09-2018
This FOA seeks to develop and test the next generation of interventions delivered through mobile health (mHealth) technology to improve diagnosis, linkage to care, retention in care, and viral suppression among youth living with human immunodeficiency virus (YLWH).

Alan T. Hirsch, MD mid- career award in vascular medicine

Due Date: 01-10-2018
The purpose of this award is to encourage participation in the Council on Peripheral Vascular Disease (PVD) and AHA activities by providing travel funds to attend the ATVB|PVD 2018 Scientific Sessions, present research in oral or poster format, and engage in discussion with senior investigators.

National Science Foundation Major Research Instrumentation Program (MRI)

Due Date: 01-10-2018
The program serves to increase access to shared scientific and engineering instruments for research and research training in our Nation's institutions of higher education, not-for-profit museums, science centers and scientific/engineering research organizations. The program provides organizations with opportunities to acquire major instrumentation that supports the research and research training goals of the organization and that may be used by other researchers regionally or nationally.

Repurposing Target-Based Pharmaceutical Libraries for Discovery of Therapeutics against Eukaryotic Pathogens (R21/R33)

Due Date: 01-12-2018
The purpose of this FOA is to solicit applications to support screening of target-based pharmaceutical libraries to identify candidate therapeutics against select eukaryotic pathogens and subsequent preclinical development activities.

American Gastroenterological Association (AGA): Boston Scientific Technology & Innovation Pilot Award

Due Date: 01-12-2018
The objective of this pilot research award is to provide funds for early career investigators or established investigators pursuing new research directions.

ISHLT/O.H. Frazier Award in MCS Translational Research Sponsored by Medtronic

Due Date: 01-15-2018
The purpose of the award is to support research utilizing MCS that would result in an increased understanding of the biologic effects, use as sole or combined therapy, insights into patient/MCS management, innovative use/application or improved outcomes for the treatment of heart failure.

Whitehall Foundation Invites LOIs for Bioscience Research Projects

Due Date: 01-15-2018
The Whitehall Foundation assists scholarly research in the life sciences through its research grants and grants-in-aid programs. It is the foundation's policy to support those dynamic areas of basic biological research that are not heavily supported by federal agencies or other foundations with a specialized mission.

NIH-CASIS Coordinated Microphysiological Systems Program for Translational Research in Space (UG3/UH3) (Clinical Trials Not Allowed)

Due Date: 01-16-2018
The purpose of this FOA is to promote the development of in vitro microphysiological systems in modeling human diseases and conditions that mimic the pathology in major organs and tissues in the human body, when exposed to the extreme environments of space, and the use of these models at the International Space Station-U.S. National Laboratory to facilitate the assessment of biomarkers, bioavailability, efficacy, and toxicity of therapeutic agents prior to entry into clinical trials.

Minority-Patient Derived Xenograft (PDX) Development & Trial Center (M-PDTC) Network (U54)

Due Date: 01-18-2018
The M-PDTCs will join the PDTC Research Network (PDXNet) and be focused upon development and pre-clinical testing of models derived from racial/ethnic minority populations. The PDXNet is a National Cancer Institute (NCI) program established to coordinate collaborative, large-scale model development and pre-clinical testing of targeted therapeutic agents to advance the vision of cancer precision medicine.

Accelerating Colorectal Cancer Screening & follow-up through Implementation Science (ACCSIS) (UG3/UH3)

Due Date: 01-18-2018
This FOA is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. The purpose is to promote research in colorectal cancer screening, follow-up, and referral-to-care among target populations for whom screening rates are below national standards. A U24 is also available.

Feasibility & Planning Studies for Development of Specialized Programs of Research Excellence (SPOREs) to Investigate Cancer Health Disparities (P20)

Due Date: 01-18-2018
This FOA invites applications for development of translational research programs that are focused upon investigating cancer health disparities. The P20 grants will support feasibility and planning activities to build cancer health disparities research programs.

Maintaining immunity after immunization (U01-clinical trial optional)

Due Date: 01-19-2018
The goal of this FOA is to improve understanding of how durable protective immunity is achieved by supporting studies that define components and mechanisms of the immune system.

BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording & Stimulating Technologies in the Human Brain (U01)

Due Date: 01-19-2018
This FOA seeks applications to assemble integrated, multi-disciplinary teams to overcome fundamental barriers. Projects should investigate high-impact questions in human neuroscience. The research should be offered as exploratory research and planning activities to establish feasibility, proof-of-principle and early-stage development that will later compete for continued funding under new or ongoing FOAs of the BRAIN Initiative or under NIH Institute appropriations.

Diabetic Foot Consortium: Clinical Research Units (U01)

Due Date: 01-23-2018
This FOA invites applications for Clinical Research Units (CRUs) to form the new Diabetic Foot Consortium (DFC) for multi-site clinical research to validate biomarkers for diabetic foot ulcers that that can predict healing outcomes, guide treatment, and monitor healing and response to treatment. The long-term goal is to lay the foundation for a clinical trial network to test therapies that can improve healing and prevent amputations.

Funding the next generation of learning-health-system researchers

Due Date: 01-24-2018
PCORI and the Agency for Healthcare Research and Quality have partnered to award up to $8 million annually in grants to train clinician and research scientists in the learning-health-systems workforce.

NIDCR Award for Sustaining Outstanding Achievement in Research (SOAR) (R35)

Due Date: 01-26-2018
The objective of the award is to provide longer-term support to NIDCR-funded investigators, who are in their mid-career stage, and have outstanding records of research productivity, mentorship, and professional service to the research community. It is expected that the award will propel the investigator along this career trajectory and allow him/her to embark on ambitious longer-term projects of extraordinary potential within the mission of NIDCR.

Innovative Molecular & Cellular Analysis Technologies for Basic & Clinical Cancer Research

Due Date: 01-28-2018
The emphasis of this FOA is on supporting the development of novel capabilities involving a high degree of technical innovation for targeting, probing, or assessing molecular and cellular features of cancer biology.

Population Assessment of Tobacco & Health (PATH) Biospecimen Access (X01)

Due Date: 01-31-2018
The PATH Study provides the scientific community with biospecimens (urine, plasma, and serum) and related research data on behaviors, attitudes, biomarkers, and health outcomes associated with tobacco use in the U.S. This opportunity allows investigators to apply for access to the biospecimens from the PATH Study.

Research Starter Grants: Translational Medicine & Therapeutics

Due Date: 02-01-2018
Translational medicine and therapeutics is a discipline focused on bridging experimental and computational research and discoveries to their application in clinical practice. To be successful, this requires working with clinicians to identify critical unmet clinical needs.

Catalyst Award in Diabetes, Endocrinology, & Metabolic Diseases (DEMD) (DP1)

Due Date: 02-02-2018
The Catalyst-DEMD is designed to complement NIDDK's traditional, investigator-initiated grant programs by supporting individual scientists who propose pioneering and possibly transforming studies in DEMD topic areas. Applications should be focused on major scientific challenges, and have the potential to produce an unusually high impact on diseases and conditions that are central to the mission of NIDDK's Division of Diabetes, Endocrinology, and Metabolic Diseases. (RFA-DK-17-011)

Biomarkers: Bridging Pediatric & Adult Therapeutics (R21)

This FOA encourages grant applications that propose adapting adult biomarkers to children. This would include the application and validation of biomarkers developed in adults to pediatric diagnosis, prognosis, and estimation of disease progression, toxicity, and response to therapy.

Research Supplements to Promote Diversity in Health-Related Research (Admin Supp)

Due Date: 12-31-2017
NIH is offering funding for administrative supplements to encourage and improve the diversity of the research workforce. This funding can help recruitment efforts and support for students, postdoctorates and eligible investigators from groups that have been underrepresented in health-related research.

Research on the Health of Transgender & Gender Nonconforming Populations (R01)

Due Date: 12-29-2017
This FOA calls for research on the health of transgender and gender nonconforming people of all ages, who are questioning their gender identity and those individuals who are making or who have made a transition from being identified as one gender to the other. This group encompasses individuals whose gender identity differs from the sex on their original birth certificate or whose gender expression varies significantly from what is traditionally associated with or typical for that sex.

Society of General Internal Medicine (SGIM) Founder's Grants

The grant will support research by a junior investigator. Applicants are encouraged to consider using the SGIM Research Dataset Compendium for their proposed research projects. This resource provides information about a number of public use datasets and provides opportunities from investigators to get mentoring and one-time consultation from senior SGIM members who are experienced in accessing and using the datasets.

NIA Academic Leadership Career Award (K07)

The objective of the award is to provide support for senior investigators who have the expertise and leadership skills to enhance aging and geriatric research capacity within their academic institution.

NIH Grants on Primary Immunodeficiency Diseases (R03/R21)

This FOA will support small grants on primary immunodeficiency diseases focusing on ex vivo studies with human specimens and on studies with current or new animal models including novel clinical strategies for detecting, identifying the molecular basis of, or developing innovative therapies for primary immunodeficiency diseases.

NIH Commons Credits Model

The NIH Commons Credits Model is a time- and cost-efficient way for NIH-funded biomedical investigators to gain cloud computing support for their current research as well as pave the way toward better accessibility, interoperability, and reuse of digital objects for future research. This is not a grant; this funding is recommended to supplement current NIH grants or to jump start a related grant in the biomedical space.

Advancing the Science of Geriatric Palliative Care (R01 & R21)

This FOA encourages exploratory or developmental research grant applications to develop new tools, methods, and models focused on palliative care in geriatric populations. The request for applications covers studies in a variety of healthcare or community settings. R01 and R21 available

RJWF Evidence for Action: Investigator-Initiated Research to Build a Culture of Health

Evidence for Action (E4A), a national program of the Robert Wood Johnson Foundation, funds research that expands the evidence base needed to build a Culture of Health. Their mission is to support rigorously designed quantitative, qualitative, and mixed methods research that yields convincing findings regarding the population health, well-being, and equity impacts of specific policies, programs and partnerships.

Ethical, Legal, & Social Implications (ELSI) of Genomics Research Project Grant Program (R01)

This FOA invites R01 applications that propose to study the ethical, legal and social implications (ELSI) of human genome research. Proposed approaches may include but are not limited to data-generating qualitative and quantitative approaches, legal, economic and normative analyses, and other types of analytical and conceptual research methodologies, such as those involving the direct engagement of stakeholders.

Small Grants for Secondary Analyses of Existing Data Sets & Stored Biospecimens (R03)

This FOA encourages applications that propose to conduct secondary analyses of publicly available NICHD-funded data sets or stored biospecimens. The goal of this program is to facilitate innovative yet cost-effective research utilizing data and biospecimens collected with NICHD resources.

NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (X02 and UG3/UH3)

The program is designed to develop partnerships between pharmaceutical companies and the biomedical research community to advance therapeutics development. X02, UG3/UH3, and pediatric UG3/UH3 available.

Quick Wins

Are you frustrated with a device that you use? Is there a clinical process you see that needs improvement? Do you have a brilliant idea for a system, device, or program that would make life better `For the Kids¿? Quick Wins is a funding program put in place to provide rapid solutions to unmet clinical and business needs at Children¿s Healthcare of Atlanta.

Training Funding Opportunities

Young Investigator Initiative

Due Date: 01-15-2018
The initiative is a mentoring and career development grant of the Bone and Joint Initiative that aims to increase the pipeline of clinicians and basic scientists undertaking musculoskeletal research studies.

Edward Mallinckrodt, Jr. Foundation Scholar Award

Due Date: 01-15-2017
The program was established to support early stage investigators engaged in biomedical research that has the potential to significantly advance the understanding, diagnosis, or treatment of disease. The funds are designed to provide faculty members who hold MD and/or PhD degrees, and are in their fifth to eighth year of a tenure-track position, with support to move the project forward to the point where other independent funding can be obtained.

Gilead sciences research scholars program in HIV

Due Date: 01-15-2018
The mission of the program is to support innovative scientific research that will advance knowledge in the field of HIV and provide support for research career development.

Beckman Center Announces History of Science Fellowships

Due Date: 01-18-2018
The Beckman Center for the History of Chemistry at the Chemical Heritage Foundation, an independent research library in Philadelphia, is inviting applications for short- or long-term fellowships in the history of science, technology, medicine, and industry.

Wistar Institute Announces The Caspar Wistar Fellows Program

Due Date: 02-21-2017
The Caspar Wistar Fellows Program will recruit two exceptional postdoctoral fellows as independent investigators, creating a springboard for the Caspar Wistar Fellows to facilitate a subsequent faculty appointment and join the next generation of scientific leaders. One Fellow with a cancer focus will be recruited to join Wistar¿s NCI-designated Cancer Center and one Fellow with vaccine/immunology expertise will be recruited to join Wistar¿s Vaccine & Immunotherapy Center.

NINDS Research Education Programs for Residents & Fellows in Neurological Disorders & Stroke (R25 - Clinical Trial Not Allowed)

Due Date: 01-23-2018
The over-arching goal of this program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation¿s biomedical, behavioral and clinical research needs. The FOA will support creative educational activities with a primary focus on research experiences, designed to foster the development of physicians as research scientists in areas relevant to the NINDS mission.

NIH Pathway to Independence Award (Parent K99/R00-Independent Clinical Trial Not Allowed)

Due Date: 01-25-2018
The purpose of the program is to increase and maintain a strong cohort of new and talented, NIH-supported, independent investigators. This program is designed to facilitate a timely transition of outstanding postdoctoral researchers with a research and/or clinical doctorate degree from mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions. The program will provide independent NIH research support during this transition in order to help awardees to launch competitive, independent research careers.

Multidisciplinary Urologic Research (KURe) Career Development Program (K12 Clinical Trial Optional)

Due Date: 02-13-2018
The purpose of this FOA is to invite applications to support institutional career development programs in urological research that will assist MDs, PhDs, and MD/PhDs with an interest in benign urological disease or urological research to develop the skills necessary to initiate and sustain an independent research career in urological research. Research areas supported by this initiative must be related to the mission of the NIDDK.

Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01)

Due Date: 02-20-2018
This FOA invites applications to enhance the pool of highly trained investigators from diverse backgrounds underrepresented in research. It is targeted toward individuals whose basic, clinical, and translational research interests are grounded in the advanced methods and experimental approaches needed to solve problems related to cardiovascular, pulmonary, and hematologic diseases and sleep disorders in the general and health disparities populations.

Emory BIRCWH Program Request for Applications

Due Date: 03-01-2018
The Emory Building Interdisciplinary Research Careers in Women's Health (BIRCWH), is a highly selective career development program for junior faculty interested in women's health research and/or sex/gender science. The ultimate goal of the BIRCWH program is to train junior faculty, through a mentored research and career development experience, to become independent investigators who use novel, interdisciplinary approaches to advance the science of women¿s health and sex/gender research. A free two-session BIRCWH application workshop will be held on November 28 and December 5.

Short-term Mentored Career Enhancement Awards for Mid-Career Investigators to Integrate Basic Behavioral & Social Sciences (K18 Clinical Trial Required)

Due Date: 03-06-2018
This FOA encourages applications for short-term mentored career development (K18) awards that improve synergies among researchers in basic and applied behavioral-social sciences, human subjects and model animals settings; and biomedical and behavioral-social sciences.

Early- & Mid-Career Faculty Encouraged to Contact NIH to Express Interest in Next Generation Research Initiative

Due Date: 12-04-2017
The initiative will allocate approximately $210 million in FY2017 and an additional $210 million each year for four years to support additional meritorious early-stage and mid-career investigators. This amount will ramp up over five years to reach approximately $1.1 billion per year.

NIDA Research Education Program for Clinical Researchers & Clinicians (R25 Clinical Trial Optional)

Due Date: 09-20-2018
The over-arching goal of this program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation¿s biomedical, behavioral and clinical research needs. This FOA is intended to support research education activities that enhance the knowledge of substance abuse and addiction research.

Commercialization Funding Opportunities

What Tech Startups Are Coke Worthy?

With a 4% Atlanta-based soft drink giant, Coca-Cola, just announced The Bridge, a six-month commercialization program to develop early-stage partnerships.

Innovation Corps (I-Corps¿) at NIH Program for NIH & CDC Translational Research (Admin Supp)

Due Date: 12-18-2017
This FOA seeks to develop and nurture a national innovation ecosystem that builds upon biomedical research to develop technologies, products, and services that benefit society. The I-Corps¿ at NIH program is focused on educating researchers and technologists on how to translate technologies from the lab into the marketplace. Under this FOA, participating NIH and CDC Institutes and Centers will continue providing administrative supplement awards to currently-funded SBIR and STTR Phase I grantees.

Cures Within Reach International Funding Supports Repurposing Research in Mental Health

Due Date: 12-22-2017
Request for Proposals posted on CureAccelerator, seeks drug, device, and nutraceutical repurposing and repositioning projects in adult, adolescent, and pediatric mental health conditions.

Advancing the Science of Multipurpose Technology for the Prevention of HIV & Unintended Pregnancy (R41/R42) (R43/R44)

Due Date: 12-22-2017
The purpose of this initiative is to invite STTR applications to stimulate new and innovative multipurpose prevention technologies through the development of new combinations of agents and delivery systems to prevent HIV infection and unintended pregnancy among adolescent girls and young women.

NCATS SBIR/STTR Applications

Due Date: 01-05-2018
The National Center for Advancing Translational Sciences (NCATS) has several open Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) program funding opportunities. SBIR and STTR funding supports small business entrepreneurs working on the advancement and commercialization of translational research technologies. NCATS encourages applications in drug discovery and development; biomedical, clinical and health research informatics; clinical, dissemination and implementation research; and clinical trials. Start the application process now to ensure a smooth submission.

Call for Applications: The Coulter Translational Program & Fund

Due Date: 01-10-2018
The Coulter Translational Fund is a validated model for successful commercialization of university-based technologies that impact patient care by license to industry or the launch of an investor-ready start-up.

Upcoming Events

View All Events

Funding News

Discovery

A Call for Student-Initiated Project Grants in Healthcare Innovation-LOIs Due December 15

The Emory-Georgia Tech Healthcare Innovation Program (HIP), in partnership with the Georgia CTSA and Georgia State University, is pleased to request applications for the third round of student grants in healthcare innovation. Grants will...

Discovery

CTSA-supported Models Contribute to the First Possible Drug Treatment for Lymphedema

A recent study led by scientists at the Stanford University School of Medicine uncovered for the first time the molecular mechanism responsible for triggering lymphedema, as well as a drug with the potential for inhibiting that process....